Skip to main content
SpringerLink
Log in
Book cover

Les cancers digestifs du sujet âgé pp 131–139Cite as

Qualité de vie

  • Chapter

  • 215 Accesses

Part of the book series: Oncologie pratique ((ONCOLPRAT))

Résumé

Les conséquences des traitements et de l’évolution des cancers ont une influence majeure sur la qualité de vie des patients. La démonstration de l’effi cacité de la chimiothérapie dans les plupart des cancers digestifs a conduit à un développement important des traitements durant la dernière décennie. Une intensifi cation thérapeutique par des polychimiothérapies associées à des thérapies ciblées est passée dans la pratique courante, notamment dans les cancers colorectaux. De plus, l’obtention d’un contrôle de la maladie cancéreuse permet à des patients de plus en plus nombreux de bénéfi cier de chirurgie des métastases. La conséquence de cette escalade thérapeutique est l’exposition des patients à une toxicité accrue des traitements. La qualité de vie devient un élément incontournable à prendre en compte lors des traitements prolongés. La spécifi cité des patients âgés impose une évaluation rigoureuse de la qualité de vie au cours de leur prise en charge. L’enjeu de la recherche thérapeutique pour cette population est de déterminer les stratégies thérapeutiques préservant au mieux la qualité de vie.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12: 608–16

    CAS  PubMed  Google Scholar 

  2. Carr AJ, Gibson B, Robinson PG (2001) Measuring quality of life: Is quality of life determined by expectations or experience? BMJ 322: 1240–3

    Article  CAS  PubMed  Google Scholar 

  3. Gotay CC (2004) Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer Inst Monogr 33: 126–33

    Article  PubMed  Google Scholar 

  4. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R (1997) Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Offi ce. Eur J Cancer 33: 20–8

    Article  CAS  PubMed  Google Scholar 

  5. Beitz J, Gnecco C, Justice R (1996) Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective. J Natl Cancer Inst Monogr 20: 7–9

    PubMed  Google Scholar 

  6. Gill TM, Feinstein AR (1994) A critical appraisal of the quality of quality-of-life measurements. JAMA 272: 619–26

    Article  CAS  PubMed  Google Scholar 

  7. Sprangers MA, Aaronson NK (1992) The role of health care providers and signifi cant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 45: 743–60

    Article  CAS  PubMed  Google Scholar 

  8. Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51: 617–31

    Article  CAS  PubMed  Google Scholar 

  9. Sloan JA, Loprinzi CL, Kuross SA et al. (1998) Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16: 3662–73

    CAS  PubMed  Google Scholar 

  10. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324: 1417

    Article  PubMed  Google Scholar 

  11. Rauch P, Miny J, Conroy T, Neyton L, Guillemin F (2004) Quality of life among diseasefree survivors of rectal cancer. J Clin Oncol 22: 354–60

    Article  PubMed  Google Scholar 

  12. Childs AL (2005) Effect of order of administration of health-related quality of life interview instruments on responses. Qual Life Res 14: 493–500

    Article  PubMed  Google Scholar 

  13. Fitzsimmons D (2004) What are we trying to measure? Rethinking approaches to health outcome assessment for the older person with cancer. Eur J Cancer Care (Engl) 13: 416–23

    Article  CAS  Google Scholar 

  14. Dempster M, Donnelly M (2000) How well do elderly people complete individualised quality of life measures: an exploratory study. Qual Life Res 9: 369–75

    Article  CAS  PubMed  Google Scholar 

  15. Pasetto LM, Falci C, Compostella A, Sinigaglia G, Rossi E, Monfardini S (2007) Quality of life in elderly cancer patients. Eur J Cancer 43: 1508–13

    Article  PubMed  Google Scholar 

  16. Hickey A, Barker M, McGee H, O’Boyle C (2005) Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics 23: 971–93

    Article  PubMed  Google Scholar 

  17. McGill JS, Paul PB (1993) Functional status and hope in elderly people with and without cancer. Oncol Nurs Forum 20: 1207–13

    CAS  PubMed  Google Scholar 

  18. Esbensen BA, Osterlind K, Roer O, Hallberg IR (2004) Quality of life of elderly persons with newly diagnosed cancer. Eur J Cancer Care (Engl) 13: 443–53

    Article  CAS  Google Scholar 

  19. Thome B, Dykes AK, Hallberg IR (2004) Quality of life in old people with and without cancer. Qual Life Res 13: 1067–80

    Article  PubMed  Google Scholar 

  20. Wedding U, Koch A, Rohrig B, Pientka L, Sauer H, Hoffken K et al. (2008) Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncol 47: 56–62

    Article  PubMed  Google Scholar 

  21. Pinquart M, Koch A, Eberhardt B, Brix C, Wedding U, Rohrig B (2006) Associations of functional status and depressive symptoms with health-related quality of life in cancer patients. Qual Life Res 15: 1565–70

    Article  CAS  PubMed  Google Scholar 

  22. Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101: 404–11

    Article  PubMed  Google Scholar 

  23. Aparicio T, Navazesh A, Boutron I, Sobhani I, Chossidow D, Martel P et al. (2006) A majority of Elderly patients routinely treated for colorectal cancer received incomplete treatment. Gut 55: A194.

    Google Scholar 

  24. Faivre-Finn C, Bouvier AM, Mitry E, Rassiat E, Clinard F, Faivre J (2002) Chemotherapy for colon cancer in a well-defi ned French population: is it under-or over-prescribed? Aliment Pharmacol Ther; 16: 353–9

    Article  CAS  PubMed  Google Scholar 

  25. Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB (2001) Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results—Medicare. J Clin Oncol 19: 3712–8

    CAS  PubMed  Google Scholar 

  26. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341: 2061–7

    Article  CAS  PubMed  Google Scholar 

  27. Beretta G, Bolina R, Cozzi C, Morabito A (1997) Should we consider the weekly (w) chemotherapy (CT) with fl uorouracil (F) + racemic folinic acid (f) a standart treatment for advanced/metastatic carcinoma of digestive tract (DTC) in elderly patients (pts)? Proc Am Soc Clin Oncol 16: 259a

    Google Scholar 

  28. Sargent DJ, Goldberg RM, Jacobson SD et al. (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345: 1091–7

    Article  CAS  PubMed  Google Scholar 

  29. Simmonds PC (2000) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321: 531–5

    Article  CAS  PubMed  Google Scholar 

  30. Adam R, Laurent C, Poston G et al. (2008) Liver resection of colorectal metastases in elderly patients: Is it worthwhile and is there an age limit? Proceedings of ASCO GI Cancer Symposium, A452

    Google Scholar 

  31. Aparicio T, Mitry E, Sa CA, Girard L (2005) Management of colorectal cancer of elderly patients. Gastroenterol Clin Biol 29: 1014–23

    Article  PubMed  Google Scholar 

  32. Arnaud JP, Schloegel M, Ollier JC, Adloff M (1991) Colorectal cancer in patients over 80 years of age. Dis Colon Rectum 34: 896–8

    Article  CAS  PubMed  Google Scholar 

  33. Mitry E, Phelip JM, Bonnetain F et al. (2008) Phase III trial of chemotherapy with or without irinotecan in the front-line treatment of metastatic colorectal cancer in elderly patients (FFCD 2001-02 trial): Results of a planned interim analysis. Proceedings of ASCO GI Cancer Symposium, A281

    Google Scholar 

  34. Thome B, Hallberg IR (2004) Quality of life in older people with cancer — a gender perspective. Eur J Cancer Care (Engl) 13: 454–63

    Article  CAS  Google Scholar 

  35. Wedding U, Pientka L, Hoffken K (2007) Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer 43: 2203–10

    Article  PubMed  Google Scholar 

  36. Extermann M, Albrand G, Chen H et al. (2003) Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 21: 3214–9

    Article  PubMed  Google Scholar 

  37. Yellen SB, Cella DF, Leslie WT (1994) Age and clinical decision making in oncology patients. J Natl Cancer Inst 86: 1766–70

    Article  CAS  PubMed  Google Scholar 

  38. Sanoff HK, Goldberg RM, Pignone MP (2007) A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patients. Clin Colorectal Cancer 6: 700–9

    Article  PubMed  Google Scholar 

  39. Effi cace F, Bottomley A, Coens C et al. (2006) Does a patient’s self-reported healthrelated quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 42: 42–9

    Article  PubMed  Google Scholar 

  40. Maione P, Perrone F, Gallo C et al. (2005) Pretreatment quality of life and functional status assessment signifi cantly predict survival of elderly patients with advanced nonsmall-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23: 6865–72

    Article  PubMed  Google Scholar 

  41. Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS et al. (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370: 2020–9

    Article  PubMed  Google Scholar 

  42. Bouvier A, Bonnetain F, Jooste V et al. (2008) Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: A population-based study. Cancer (in press)

    Google Scholar 

  43. Seymour MT, Maughan TS, Wasan HS et al. (2007) Capecitabine (Cap) and oxaliplatin (Ox) in elderly and/or frail patients with metastatic colorectal cancer: The FOCUS2 trial. J Clin Oncol 25 (18S)

    Google Scholar 

  44. Viret F, Bugat R, Ducreux M et al. (2007) XELOX regimen in elderly patients with metastatic colorectal cancer (MCRC), a FNCLCC French Collaborative Group GERICO 02 phase II study. J Clin Oncol 25 (18S)

    Google Scholar 

  45. Francois E, Berdah JF, Chamorey E et al. (2008) Use of the folinic acid/5-fl uorouracil/ irinotecan (FOLFIRI 1) regimen in elderly patients as a fi rst-line treatment for metastatic colorectal cancer: a Phase II study. Cancer Chemother Pharmacol in press

    Google Scholar 

  46. Scappaticci FA, Skillings JR, Holden SN et al. (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99: 1232–9

    Article  PubMed  Google Scholar 

  47. Van Cutsem E, Peeters M, Siena S et al. (2007) A phase III randomized controlled trial of panitumumab (Pmab) in patients (pts) with metastatic colorectal cancer (mCRC): Subset analyses in elderly pts and in pts with poor performance status. Proceedings of ASCO GI Cancer Symposium, A349

    Google Scholar 

  48. Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10: 407–15

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépato-gastroentérologie, CHU Bichat, 46, rue Henri-Huchard, 75877, Paris Cedex 18

    Thomas Aparicio

  2. Unité de biostatistique et d’épidémiologie, Centre George François Leclerc, 1 rue Pr. Marion, BP 77980, 21079, Dijon Cedex

    Franck Bonnetain

Authors
  1. Thomas Aparicio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franck Bonnetain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Aparicio, T., Bonnetain, F. (2010). Qualité de vie. In: Les cancers digestifs du sujet âgé. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0000-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0000-4_8

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-79513-8

  • Online ISBN: 978-2-8178-0000-4

Publish with us

Policies and ethics

Search

Navigation